3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
63
Carcinoma, Intraductal, Noninfiltrating
8
Breast Carcinoma In Situ
6
Neoplasms
4
Breast Neoplasms, Male
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Infertility
2
Endometrial Neoplasms
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Pinealoma
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Medulloblastoma
1
Inflammatory Breast Neoplasms
1
Hypogonadism
1
Hyperglycemia
1
Hot Flashes
1
Interventions
Bevacizumab
69
atezolizumab
54
durvalumab
43
lenvatinib
42
Nivolumab
38
pembrolizumab
35
tremelimumab
29
Magnetic Resonance Spectroscopy
21
Specimen Handling
19
tislelizumab
18
sintilimab
17
Ipilimumab
15
Sorafenib
14
regorafenib
13
cabozantinib
13
Radiosurgery
13
Radiotherapy
12
apatinib
11
Blood Specimen Collection
11
Immunoglobulin G
10
camrelizumab
9
Immune Checkpoint Inhibitors
9
Disulfides
9
X-Rays
8
Cyclophosphamide
8
donafenib
7
Oxaliplatin
7
Immunotherapy
7
Folfox protocol
7
Fluorouracil
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Tamoxifen
×
1 year
×
Clear all
No trials found.